Literature DB >> 1362222

A new mutant transthyretin (Arg 10) associated with familial amyloid polyneuropathy.

T Uemichi1, J R Murrell, S Zeldenrust, M D Benson.   

Abstract

We report a new kindred with systemic amyloidosis presenting as peripheral neuropathy in the sixth and seventh decades of life. Polymorphism in exon 2 of the transthyretin (TTR) gene was suggested by single strand conformation polymorphism analysis and determined by direct DNA sequencing. We also developed restriction fragment length polymorphism analysis by polymerase chain reaction using a primer with an induced mutation. The point mutation (cytosine for thymine at position 1038 of the TTR gene) is responsible for substitution of arginine for cysteine at position 10 of the TTR molecule. It is hypothesised that the TTR molecules which have no cysteine have a unique structure in heterozygous TTR polymers and are responsible for amyloid fibril formation.

Entities:  

Mesh:

Substances:

Year:  1992        PMID: 1362222      PMCID: PMC1016207          DOI: 10.1136/jmg.29.12.888

Source DB:  PubMed          Journal:  J Med Genet        ISSN: 0022-2593            Impact factor:   6.318


  9 in total

1.  A mutation in apolipoprotein A-I in the Iowa type of familial amyloidotic polyneuropathy.

Authors:  W C Nichols; R E Gregg; H B Brewer; M D Benson
Journal:  Genomics       Date:  1990-10       Impact factor: 5.736

2.  Rapid and sensitive detection of point mutations and DNA polymorphisms using the polymerase chain reaction.

Authors:  M Orita; Y Suzuki; T Sekiya; K Hayashi
Journal:  Genomics       Date:  1989-11       Impact factor: 5.736

Review 3.  Inherited amyloidosis.

Authors:  M D Benson
Journal:  J Med Genet       Date:  1991-02       Impact factor: 6.318

4.  Detection of polymorphisms of human DNA by gel electrophoresis as single-strand conformation polymorphisms.

Authors:  M Orita; H Iwahana; H Kanazawa; K Hayashi; T Sekiya
Journal:  Proc Natl Acad Sci U S A       Date:  1989-04       Impact factor: 11.205

5.  Structure of the human prealbumin gene.

Authors:  T Tsuzuki; S Mita; S Maeda; S Araki; K Shimada
Journal:  J Biol Chem       Date:  1985-10-05       Impact factor: 5.157

6.  DNA banking: the effects of storage of blood and isolated DNA on the integrity of DNA.

Authors:  L Madisen; D I Hoar; C D Holroyd; M Crisp; M E Hodes
Journal:  Am J Med Genet       Date:  1987-06

7.  Hereditary generalized amyloidosis with polyneuropathy. Clinicopathological study of 65 Japanese patients.

Authors:  S Ikeda; N Hanyu; M Hongo; J Yoshioka; H Oguchi; N Yanagisawa; T Kobayashi; H Tsukagoshi; N Ito; T Yokota
Journal:  Brain       Date:  1987-04       Impact factor: 13.501

8.  Direct sequencing of the gene for Maryland/German familial amyloidotic polyneuropathy type II and genotyping by allele-specific enzymatic amplification.

Authors:  W C Nichols; J J Liepnieks; V A McKusick; M D Benson
Journal:  Genomics       Date:  1989-10       Impact factor: 5.736

9.  Familial amyloid polyneuropathy related to transthyretin Gly42 in a Japanese family.

Authors:  T Uemichi; S Ueno; H Fujimura; T Umekage; S Yorifuji; Y Matsuzawa; S Tarui
Journal:  Muscle Nerve       Date:  1992-08       Impact factor: 3.217

  9 in total
  8 in total

1.  Amyloid polyneuropathy in two German-American families: a new transthyretin variant (Val 107).

Authors:  T Uemichi; M A Gertz; M D Benson
Journal:  J Med Genet       Date:  1994-05       Impact factor: 6.318

2.  Rigorous treatment of multispecies multimode ligand-receptor interactions in 3D-QSAR: CoMFA analysis of thyroxine analogs binding to transthyretin.

Authors:  Senthil Natesan; Tiansheng Wang; Viera Lukacova; Vladimir Bartus; Akash Khandelwal; Stefan Balaz
Journal:  J Chem Inf Model       Date:  2011-04-08       Impact factor: 4.956

3.  A new transthyretin variant (Ser 24) associated with familial amyloid polyneuropathy.

Authors:  T Uemichi; M A Gertz; M D Benson
Journal:  J Med Genet       Date:  1995-04       Impact factor: 6.318

Review 4.  Unifying features of systemic and cerebral amyloidosis.

Authors:  J Ghiso; T Wisniewski; B Frangione
Journal:  Mol Neurobiol       Date:  1994-02       Impact factor: 5.590

5.  Hereditary renal amyloidosis with a novel variant fibrinogen.

Authors:  T Uemichi; J J Liepnieks; M D Benson
Journal:  J Clin Invest       Date:  1994-02       Impact factor: 14.808

6.  Cysteine 10 is a key residue in amyloidogenesis of human transthyretin Val30Met.

Authors:  Yutaka Takaoka; Mika Ohta; Kazuhisa Miyakawa; Osamu Nakamura; Misao Suzuki; Kiyoshi Takahashi; Ken-Ichi Yamamura; Yoshiyuki Sakaki
Journal:  Am J Pathol       Date:  2004-01       Impact factor: 4.307

7.  Hereditary transthyretin-related amyloidosis is frequent in polyneuropathy and cardiomyopathy of no obvious aetiology.

Authors:  Volha Skrahina; Ulrike Grittner; Christian Beetz; Thomas Skripuletz; Martin Juenemann; Heidrun H Krämer; Katrin Hahn; Andreas Rieth; Volker Schaechinger; Monica Patten; Christian Tanislav; Stephan Achenbach; Birgit Assmus; Fabian Knebel; Stefan Gingele; Aliaksandr Skrahin; Jörg Hartkamp; Toni M Förster; Sabine Roesner; Catarina Pereira; Arndt Rolfs
Journal:  Ann Med       Date:  2021-12       Impact factor: 4.709

Review 8.  Ocular Involvement in Hereditary Amyloidosis.

Authors:  Angelo Maria Minnella; Roberta Rissotto; Elena Antoniazzi; Marco Di Girolamo; Marco Luigetti; Martina Maceroni; Daniela Bacherini; Benedetto Falsini; Stanislao Rizzo; Laura Obici
Journal:  Genes (Basel)       Date:  2021-06-22       Impact factor: 4.096

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.